Long-term outcomes following Foscan®-PDT of basal cell carcinomas. - Wikidata - wikimedia - TriplyDB

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

http://www.wikidata.org/entity/Q34360733

about

mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.Self-assembled liposomal nanoparticles in photodynamic therapy.Photodynamic therapy in the upper aerodigestive tract. Overview and outlook.

P2860

Q35805252-C465AF2B-0E23-4B93-BD5E-C1B1CC30CA71 Q38172124-77168B90-0861-4AEF-85A6-CEE5E41C41E8 Q38787155-2A35DD1A-1DC8-4D26-AC83-75E57A6A063E

P2860

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

http://www.wikidata.org/entity/Q34360733

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@ast

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@en

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@nl

type

label

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@ast

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@en

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@nl

prefLabel

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@ast

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@en

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@nl

P1433

Q34360733-6A29C27C-8F7E-401F-8894-D3E416548DA4

P1476

Q34360733-FE1579C8-F08F-4A75-930A-4B17B89ED5A9

P2093

Q34360733-077852CA-4CF2-414A-99F0-C05B5F655712

Q34360733-0B941CE1-F282-4033-ADDD-37281D3D094C

Q34360733-343F1E67-609B-48A3-A46A-63115CFD166E

Q34360733-6DFC1BF7-E0CD-4D3F-8CD8-25E805A232CE

Q34360733-7F793011-E473-4E63-AC79-281E67A623DA

Q34360733-8C296AB9-147E-4831-AE58-5346B8E58F3D

Q34360733-AC897345-89D3-4FA0-BD3F-F83D38DFDEFA

Q34360733-C38A7399-E649-4549-9856-612935FF9E7E

P2860

Q34360733-012BC79A-D8C5-43E8-8991-47BF888CA31B

Q34360733-117BB9FF-64C6-448D-A11F-C0F70612AEC0

Q34360733-16C8A07C-5336-4343-B66B-7E2069E8B47F

Q34360733-2E2586FE-F1A9-4424-B275-D83BE6300753

Q34360733-30520A57-0D5F-4CB6-8ED1-A9CA164B79D6

Q34360733-4328AFFA-E4CC-49BF-A976-2566481AF93F

Q34360733-43712741-3968-4EBA-AE5E-5892E9BF5868

Q34360733-4F2D7982-DD91-4B17-9574-272DA8DD6327

Q34360733-55C61E08-D244-45F5-B8E0-AEAA285377E7

Q34360733-6C6B0548-F92C-4AD4-88E9-95883844FB87

P304

Q34360733-ECE124BD-AF3C-4E63-AD95-8A66E5C54A08

P31

Q34360733-CB990621-5C45-4BF5-91B0-57364D224C39

P356

Q34360733-42ED1B0F-C28F-49DA-B010-6A817BF8B2DA

P433

Q34360733-9E3D3B60-AFDA-45D2-80C8-A084539F0990

P478

Q34360733-D27636B9-AAE9-4F1E-9D57-10095F3C2F29

P577

Q34360733-57B88FED-D4E4-445E-8538-9DE1D1F574CE

P698

Q34360733-665504F4-F0BC-4CBA-8B9A-82DBE52AD097

P356

P1433

Lasers in Surgery and Medicine

P1476

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.

@en

P2093

Christian S Betz

http://www.w3.org/2001/XMLSchema#string

Colin Hopper

http://www.w3.org/2001/XMLSchema#string

Evgueni Ph Stranadko

http://www.w3.org/2001/XMLSchema#string

Mikhail V Riabov

http://www.w3.org/2001/XMLSchema#string

Nikolay E Nifantiev

http://www.w3.org/2001/XMLSchema#string

Valery N Volgin

http://www.w3.org/2001/XMLSchema#string

Volker Albrecht

http://www.w3.org/2001/XMLSchema#string

Winrich Rauschning

http://www.w3.org/2001/XMLSchema#string

P2860

Interventions for basal cell carcinoma of the skin

Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck.

Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.

MAL-PDT for difficult to treat nonmelanoma skin cancer.

Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision.

Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.

Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.

A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.

Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial.

Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.

P304

533-540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LSM.22056

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22851213

http://www.w3.org/2001/XMLSchema#string